Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty

Next Previous
Search
Trial Profile

Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 04 Dec 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Postoperative pain
  • Focus Pharmacokinetics

Most Recent Events

  • 04 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2017.
  • 12 Nov 2015 Planned end date changed from 1 Dec 2015 to 1 Jun 2016, as reported by ClinicalTrials.gov.
  • 12 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top